Author:
Wasan Kishor M.,Goss Paul E.,Pritchard P. Haydn,Shepherd Lois,Tu Dongsheng,Ingle James N.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Wasan KM, Ramaswamy M, Haley J et al (1997) Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer. J Pharm Sci 86:876–879
2. Goss PE, Ingle JN, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after 5 years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793–1802
3. Harper-Wynne C, Ross G, Sacks N et al (2002) Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. Cancer Epidemiol Biomarkers Prev 11:614–621
4. Heshmati HM, Khosla S, Robins SP et al (2002) Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 17:172–178
5. Elisaf MS, Bairaktari ET, Nicolaides C et al (2001) Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. Eur J Cancer 37:1510–1513
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献